RU2195935C2 - Фармацевтические композиции, содержащие ибупрофен и домперидон для лечения мигрени - Google Patents

Фармацевтические композиции, содержащие ибупрофен и домперидон для лечения мигрени Download PDF

Info

Publication number
RU2195935C2
RU2195935C2 RU99119233/14A RU99119233A RU2195935C2 RU 2195935 C2 RU2195935 C2 RU 2195935C2 RU 99119233/14 A RU99119233/14 A RU 99119233/14A RU 99119233 A RU99119233 A RU 99119233A RU 2195935 C2 RU2195935 C2 RU 2195935C2
Authority
RU
Russia
Prior art keywords
ibuprofen
domperidone
pharmaceutically acceptable
acceptable salt
appropriate amount
Prior art date
Application number
RU99119233/14A
Other languages
English (en)
Russian (ru)
Other versions
RU99119233A (ru
Inventor
Махендра Говинд ПАНКХАНИА (GB)
Махендра Говинд ПАНКХАНИА
Сарухан ЮРДАКУЛ (GB)
Сарухан ЮРДАКУЛ
Original Assignee
Дзе Бутс Компани ПЛС
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Дзе Бутс Компани ПЛС filed Critical Дзе Бутс Компани ПЛС
Publication of RU99119233A publication Critical patent/RU99119233A/ru
Application granted granted Critical
Publication of RU2195935C2 publication Critical patent/RU2195935C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
RU99119233/14A 1997-02-06 1998-02-03 Фармацевтические композиции, содержащие ибупрофен и домперидон для лечения мигрени RU2195935C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9702392.3 1997-02-06
GBGB9702392.3A GB9702392D0 (en) 1997-02-06 1997-02-06 Therapeutic agents

Publications (2)

Publication Number Publication Date
RU99119233A RU99119233A (ru) 2001-07-20
RU2195935C2 true RU2195935C2 (ru) 2003-01-10

Family

ID=10807167

Family Applications (1)

Application Number Title Priority Date Filing Date
RU99119233/14A RU2195935C2 (ru) 1997-02-06 1998-02-03 Фармацевтические композиции, содержащие ибупрофен и домперидон для лечения мигрени

Country Status (25)

Country Link
EP (1) EP1017388B1 (da)
JP (1) JP2001511168A (da)
KR (1) KR20000070823A (da)
CN (1) CN1115150C (da)
AR (1) AR011437A1 (da)
AT (1) ATE247466T1 (da)
AU (1) AU724526B2 (da)
BG (1) BG64371B1 (da)
CA (1) CA2279184C (da)
CZ (1) CZ295374B6 (da)
DE (1) DE69817379T2 (da)
DK (1) DK1017388T3 (da)
ES (1) ES2205452T3 (da)
GB (2) GB9702392D0 (da)
HU (1) HU225043B1 (da)
ID (1) ID22416A (da)
IL (1) IL131230A0 (da)
NO (1) NO993784L (da)
PL (1) PL190733B1 (da)
PT (1) PT1017388E (da)
RU (1) RU2195935C2 (da)
SK (1) SK284728B6 (da)
TR (1) TR199901782T2 (da)
WO (1) WO1998034612A1 (da)
ZA (1) ZA98968B (da)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2796537C2 (ru) * 2018-10-25 2023-05-25 Синдом Фарма, Инк. Составы, содержащие дейтерированный домперидон

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9816899D0 (en) * 1998-08-05 1998-09-30 Boots Co Plc Therapeutic agents
GB9822333D0 (en) * 1998-10-13 1998-12-09 Merck Sharp & Dohme Pharmaceutical formulation
HU227045B1 (en) * 1999-12-09 2010-05-28 Reckitt Benckiser Healthcare Compressed tablet composition comprising a nsaid
GB0229258D0 (en) * 2002-12-16 2003-01-22 Boots Healthcare Int Ltd Medicinal compositions
US20060068009A1 (en) * 2004-09-30 2006-03-30 Scolr Pharma, Inc. Modified release ibuprofen dosage form
US20070077297A1 (en) 2004-09-30 2007-04-05 Scolr Pharma, Inc. Modified release ibuprofen dosage form
CN101068532B (zh) * 2004-09-30 2012-03-14 斯科尔医药公司 布洛芬改进释放剂型
DE102005013726A1 (de) * 2005-03-22 2006-09-28 Grünenthal GmbH Transdermale therapeutische Systeme mit verbesserter Verträglichkeit
US7749537B2 (en) 2006-12-04 2010-07-06 Scolr Pharma, Inc. Method of forming a tablet
EP2142176A1 (en) * 2007-04-26 2010-01-13 Craig A. Aronchick Compositions and methods for transmucosal delivery of domperidone
CN107773560A (zh) * 2016-08-25 2018-03-09 厦门恩成制药有限公司 一种具有止痛和消炎作用的药用组合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2020018A1 (en) * 1990-06-27 1991-12-28 Don L. Simmons Method and composition for treating the migraine complex
GB2313309B (en) * 1996-05-24 2000-01-26 Ninh Thuy On Pharmaceutical compositions comprising a nonsteroidal anti-inflammatory drug and domperidone in the treatment of migraine

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
D. KLINGLER ET AL Migrane-Therapie. - DESTERREICHISCHE AERZTEZEITUNG, v.49, №24, 1994. *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2796537C2 (ru) * 2018-10-25 2023-05-25 Синдом Фарма, Инк. Составы, содержащие дейтерированный домперидон

Also Published As

Publication number Publication date
DK1017388T3 (da) 2003-10-13
AR011437A1 (es) 2000-08-16
PL335089A1 (en) 2000-04-10
SK284728B6 (sk) 2005-10-06
CZ270999A3 (cs) 1999-10-13
GB9904285D0 (en) 1999-04-21
HUP0001104A3 (en) 2000-09-28
IL131230A0 (en) 2001-01-28
TR199901782T2 (xx) 1999-09-21
HU225043B1 (en) 2006-05-29
DE69817379T2 (de) 2004-06-09
CA2279184A1 (en) 1998-08-13
HUP0001104A2 (hu) 2000-08-28
BG103632A (en) 2000-03-31
GB2331926A (en) 1999-06-09
EP1017388A1 (en) 2000-07-12
ATE247466T1 (de) 2003-09-15
WO1998034612A1 (en) 1998-08-13
AU724526B2 (en) 2000-09-21
DE69817379D1 (de) 2003-09-25
EP1017388B1 (en) 2003-08-20
ES2205452T3 (es) 2004-05-01
CN1246795A (zh) 2000-03-08
AU6295598A (en) 1998-08-26
KR20000070823A (ko) 2000-11-25
SK106299A3 (en) 2000-08-14
CA2279184C (en) 2009-04-21
CZ295374B6 (cs) 2005-07-13
ZA98968B (en) 1998-08-06
NO993784L (no) 1999-09-22
GB2331926B (en) 2000-07-12
GB9702392D0 (en) 1997-03-26
NO993784D0 (no) 1999-08-05
CN1115150C (zh) 2003-07-23
JP2001511168A (ja) 2001-08-07
PT1017388E (pt) 2003-12-31
ID22416A (id) 1999-10-14
PL190733B1 (pl) 2005-12-30
BG64371B1 (bg) 2004-12-30

Similar Documents

Publication Publication Date Title
CN1296040C (zh) 药物组合物
CA2318128C (en) Oral liquid compositions
US20030008003A1 (en) Compositions for enhanced absorption of NSAIDs
US20080255104A1 (en) Nsaid Compositions
US6242000B1 (en) Composition of S−sodium ibuprofen
ES2337547T3 (es) Composiciones de liberacion controlada que contienen nimesulida.
KR20080033354A (ko) 카르비도파 및 레보도파를 함유하는 고형의 연장 방출약학적 조성물
RU2195935C2 (ru) Фармацевтические композиции, содержащие ибупрофен и домперидон для лечения мигрени
KR20020050223A (ko) 경구용 액제 조성물
US20050249808A1 (en) NSAIDs compositions containing tartaric acid
US20040204403A1 (en) Pharmaceutical composition comprising ibuprofen and prochlorperazine
RU2493843C2 (ru) Содержащие ацеклофенак пероральные лекарственные средства с контролируемым высвобождением и способ их изготовления
ES2604254T3 (es) Combinaciones de flurbiprofeno de liberación controlada y relajante muscular
WO2015157729A1 (en) Pharmaceutical formulations an comprising analgesic agent, a nonsteroidal anti-inflammatory agent, a gastric acid production suppressant and an anti-nauseant
JPH11510168A (ja) 呼吸障害を処理するための鎮痛剤及び抗ヒスタミン剤を含有する組成物及び方法
JPH08506808A (ja) 呼吸障害治療用組成物の製造における鎮痛剤ｓ（＋）対掌体の利用
AU2003224419A1 (en) Orally administrable pharmaceutical formulation
JPWO2004017954A1 (ja) ジクロフェナクの副作用軽減剤
WO2002083110A2 (en) Animal model for evaluating analgesics
KR20010069756A (ko) 소염진통제인 아세메타신을 함유하며 장관내 특히대장에서의 약물 방출 속도가 조절되는 약물 전달 체계에대한 약제학적 경구용 조성물 및 그에 대한 제조방법

Legal Events

Date Code Title Description
PC4A Invention patent assignment

Effective date: 20070328

PC41 Official registration of the transfer of exclusive right

Effective date: 20070609

MM4A The patent is invalid due to non-payment of fees

Effective date: 20170204